Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c639
Identifier NCT06290934
Trial Title Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: emvistegrast|DRUG: Placebo-to-match emvistegrast
Participant Information
Sponsor Gilead Sciences
City Peoria
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2024-03-27
Primary Completion Date 2026-03-04
Completion Date 2028-04